Schizophrenia Completed Phase Trials for Tetrahydropalmatine (DB12093)

Also known as: Dementia Praecox / Schizophrenic Disorders / Schizophrenic Disorder / Schizophrenia NOS / Schizophrenia, unspecified / Unspecified schizophrenia / Unspecified schizophrenia, unspecified state

IndicationStatusPhase
DBCOND0018504 (Schizophrenia)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02118610Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal ActivityTreatment